These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 1173764

  • 21. [Controlled clinical study on the use of morniflumate in the treatment of inflammatory-degenerative diseases of the locomotor system].
    Raffaetà G, Saponati G, Terzuoli A.
    G Clin Med; 1987 Oct; 68(10):507-13. PubMed ID: 3428515
    [No Abstract] [Full Text] [Related]

  • 22. [Clinical study of the activity of nuflumic acid in the postoperative period in dental surgery].
    Combres M, Kneip L, Munier C, Souchaud L.
    Rev Odontoimplantol; 1974 Oct; 54(6):13-7. PubMed ID: 4535158
    [No Abstract] [Full Text] [Related]

  • 23. [Niflumic acid combined with gastroprotective agents in rheumatic pathology].
    Serni U, Frosecchi M.
    Reumatismo; 1974 Oct; 26(2):109-28. PubMed ID: 4282512
    [No Abstract] [Full Text] [Related]

  • 24. Combined drug treatment of neurological inflammatory processes.
    Perényi G.
    Ther Hung; 1981 Oct; 29(4):186-90. PubMed ID: 7188145
    [No Abstract] [Full Text] [Related]

  • 25. [Clinical evaluation of the preparation Donalgin in the treatment of rheumatoid arthritis and ankylosing spondylitis].
    Sadkiewicz S, Barwik-Schramm A, Grzywa M, Letkiewicz C, Piotrowska E, Procel Z, Reszkowska H, Wippel A, Woźniak M, Zmudzińska I.
    Reumatologia; 1982 Oct; 20(1-2):75-80. PubMed ID: 6761815
    [No Abstract] [Full Text] [Related]

  • 26. [Anti-proteinuric effect of indomethacin in glomerulopathies (nephrotic syndrome, acute glomerulonephritis and chronic glomerulonephritis). Preliminary note].
    Conte J, Suc JM, Mignon-Conte M.
    J Urol Nephrol (Paris); 1967 Oct; 73(10):850-6. PubMed ID: 5596281
    [No Abstract] [Full Text] [Related]

  • 27. [Niflumic acid in otorhynolaryngologic inflammation in childhood. Controlled study versus feprazone].
    Tarantino V, Stura M, Cremonesi G.
    Minerva Pediatr; 1985 Oct 31; 37(20):827-32. PubMed ID: 3912657
    [No Abstract] [Full Text] [Related]

  • 28. New means in the treatment of locomotor disorders of aged patients.
    Porkoláb E.
    Ther Hung; 1978 Oct 31; 26(4):190-2. PubMed ID: 751278
    [No Abstract] [Full Text] [Related]

  • 29. [Trabeculoretraction and anti-inflammatory agents].
    Audoueineix E, Le Breton-Oliveau G, Chabanais JL.
    Bull Soc Ophtalmol Fr; 1987 Apr 31; 87(4):541-3. PubMed ID: 3652371
    [No Abstract] [Full Text] [Related]

  • 30. Clinical effectivity of Donalgin--niflumic acid--in locomotor diseases.
    Krakovits G, Tallián A, Képes P.
    Ther Hung; 1981 Apr 31; 29(2):77-85. PubMed ID: 6765143
    [No Abstract] [Full Text] [Related]

  • 31. Use of a new anti-inflammatory agent, bucloxic acid, in the treatment of chronic glomerular nephropathies.
    Lagrue G, Masbernard A, Giudicelli C, Hirbec G.
    Arzneimittelforschung; 1974 Sep 31; 24(9A SUPPL):1434-9. PubMed ID: 4614821
    [No Abstract] [Full Text] [Related]

  • 32. The effect of Donalgin on locomotor disease.
    Abrányi I, Papp I.
    Ther Hung; 1977 Sep 31; 25(1):20-3. PubMed ID: 854866
    [No Abstract] [Full Text] [Related]

  • 33. [Effects of corticosteroid and indomethacin treatment on proteinuria].
    Michielsen P, Lambert PP.
    Bull Mem Soc Med Hop Paris; 1967 Feb 10; 118(3):217-32. PubMed ID: 6058837
    [No Abstract] [Full Text] [Related]

  • 34. Examinations with Donalgin in locomotor diseases treated at the out-patient department.
    Kovács E.
    Ther Hung; 1977 Feb 10; 25(2):75-8. PubMed ID: 302503
    [No Abstract] [Full Text] [Related]

  • 35. [The treatment of nephrotic-type chronic glomerulonephritis with Sandimmun (cyclosporin A)].
    Mukhin NA, Tareeva IE, Krasnova TN, Shilov EM, Miroshnichenko NG.
    Ter Arkh; 1995 Feb 10; 67(8):13-5. PubMed ID: 7482320
    [Abstract] [Full Text] [Related]

  • 36. [Comparative trial by double-blind method of a niflumic acid derivative and oxyphenbutazone in pediatric O. R. L].
    Traissac L, Roche JC.
    Rev Laryngol Otol Rhinol (Bord); 1979 Feb 10; 100(1-2):151-61. PubMed ID: 379941
    [No Abstract] [Full Text] [Related]

  • 37. [Use of an anti-inflammatory agent, well tolerated by children, in the O.R.L. surgery].
    Morgon AH, Dubreuil C.
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1978 Jun 10; 27(6):419-22. PubMed ID: 151729
    [No Abstract] [Full Text] [Related]

  • 38. [Clinical studies of a new local treatment].
    Laufer J.
    Inf Dent; 1983 Mar 10; 65(10):909-12. PubMed ID: 6574974
    [No Abstract] [Full Text] [Related]

  • 39. Potentiation of Donalgin in the treatment of postinjection and postinfusion phlebitis.
    Horváth I, Illés T.
    Ther Hung; 1980 Mar 10; 28(4):171-5. PubMed ID: 7209850
    [No Abstract] [Full Text] [Related]

  • 40. [Value of the beta-morpholino-ethylic ester of niflumic acid in children].
    Vanegroo A, Foulard M.
    Lille Med; 1979 May 10; 24(5):418-20. PubMed ID: 502730
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.